RxDoctor Payments DataLook up a doctor →

Eric Schaefer, MD

Hematology & Oncology · Fayetteville, ARNPI 1558325118

Payments from drug & device makers

$5,178,833in general payments, 2019–2025

Across 1,485 payments — averaging $3487.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2.3M
  • AstraZeneca$587K
  • AbbVie$585K
  • Eli Lilly$445K
  • Daiichi Sankyo Inc.$355K
  • Cornerstone Specialty Network LLC$268K
  • plus $660K from 54 others
$2,935in research payments, 2019–2025

Across 5 payments — averaging $587.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$3K
  • Eli Lilly$100

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis82$2,278,708
AstraZeneca(2 entities)78$586,566
AbbVie123$584,713
Eli Lilly17$445,058
Daiichi Sankyo Inc.328$355,075
Cornerstone Specialty Network LLC84$268,167
Mirati Therapeutics, Inc.75$234,800
Merck41$136,493
Boehringer Ingelheim25$64,885
Argenx US, Inc.11$30,044
Onmark, Inc.35$26,922
Astrazeneca UK Limited2$25,100
Genentech, Inc.4$24,260
E.r. Squibb & Sons, L.L.C.19$23,571
Amgen49$19,201
Pfizer20$10,445
Boehringer Ingelheim International GmbH2$8,460
Bayer10$7,758
Sanofi US Services Inc.6$6,711
Regeneron Healthcare Solutions, Inc.35$4,740
Blueprint Medicines Corporation11$4,605
Taiho Oncology, Inc.8$2,840
GSK13$2,837
Exelixis Inc.13$2,822
Johnson & Johnson(2 entities)58$2,789
Sanofi24$2,402
EMD Serono, Inc.18$2,287
Jazz Pharmaceuticals Inc.22$1,672
Seagen Inc.11$1,429
Beigene, Ltd.2$1,403
TG Therapeutics, Inc.2$1,361
Heron Therapeutics, Inc.2$1,313
Athenex Pharmaceutical Division, LLC1$1,250
Janssen Scientific Affairs, LLC2$1,206
AVEO Pharmaceuticals, Inc.11$1,200
Coherus Oncology, Inc.1$900
Janssen Global Services, LLC1$575
Bristol Myers Squibb35$369
Takeda Pharmaceuticals U.S.A., Inc.16$254
Genentech USA, Inc.14$240
Gilead(2 entities)18$234
Novocure GmbH1$200
Lilly USA, LLC15$199
Caris MPI, Inc.2$196
Intuitive Surgical2$195
Ipsen Biopharmaceuticals, Inc11$195
Beigene USA, Inc.5$187
Eisai Inc.11$154
Astellas Pharma US Inc10$149
Incyte Corporation8$116
Array Biopharma Inc7$104
Comsort, Inc1$100
Amneal Pharmaceuticals LLC1$95
Sumitomo Pharma America, Inc.5$85
Kyowa Kirin, Inc.6$84
Pharmacosmos Therapeutics Inc.4$68
G1 Therapeutics, Inc.5$66
Puma Biotechnology, Inc.4$64
Pharmacyclics LLC, An Abbvie Company4$63
Sobi, Inc4$60

How this compares

$5,178,833 in reported general payments places this provider in the 95th percentile of 92 hematology & oncology providers in Arkansas.

See all hematology & oncology providers in Arkansas →

Medicare billing

Part B allowed, 2024
$6,362,468
Medicare patients
1,492
Services billed
313,522

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Fayetteville

See the full list for Arkansas →

Where these figures come from

Is this you, or does something look wrong? →